MARVELL TECHNOLOGY, INC (MRVL): what the price requires
At today's price, MARVELL TECHNOLOGY, INC (MRVL) is priced for today's economics sustained for ~36.2 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Source: https://boothcheck.com/report/MRVL
Headline
| Field | Value |
|---|---|
| Ticker | MRVL |
| Company | MARVELL TECHNOLOGY, INC |
| Current price | $218.61/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin today | 15.0% |
| Must persist for | 36.2y |
| Multiple paid | 153x operating income |
Solve inputs: computed at a 14.6% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~4.7 years.
Reconcile: at the x-ray's 9.3% required return this reads ~18.2 years; the models below use their own rates.
How unusual the bet is: elevated (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~10 years at this level | 15% |
| implied end-window share | 16% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 12.67x | 1 | expensive |
| Earnings | 11.12x | 2 | expensive |
| Relative | 6.91x | 4 | expensive |
| Growth | 1.29x | 3 | expensive |
Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.
Per-Model Detail (n=10)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $79.20 | 2.76x | yes | FCF base $1.8B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.0%, 7yr projection |
| DCF Exit Multiple | Growth | $232.59 | 0.94x | yes | Exit EV/EBITDA: 138.4x / 141.4x / 144.4x (bear / base = today's held flat / bull), 7yr |
| Relative Valuation | Relative | $45.25 | 4.83x | yes | P/E 48.4x (blended: static sector reference 22x + trailing (TTM) 341x), scenarios: 38.7x / 48.4x / 58.1x (bear / base = reference held flat / bull), EV/EBITDA 35.2x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $6.93 | 31.55x | yes | BV/sh $20.39, ROE (TTM) 3.1%, ke 9.3% (excluded from median) |
| Two-Stage Excess Return | Asset | $4.17 | 52.42x | yes | 5yr excess ROE then converge to ke=9.3% (excluded from median) |
| Discounted Future Market Cap | Growth | $169.91 | 1.29x | yes | Rev $8.7B, growth 30% (input: historical growth; tapered), Terminal P/S: 9.6x / 12.0x / 14.4x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $7.78 | 28.10x | yes | EPS $0.65, growth 1% (input: historical EPS growth), PEG=228.38 (Overvalued) (excluded from median) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $0.15 | 1457.40x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.18B × (1−21%) / WACC 9.0% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $3.11 | 70.29x | yes | BV $20.39 + 5yr PV of (ROE (TTM) 3.1% − Kₑ 9.3%) × BV; BV grows 2.0%/yr (excluded from median) |
| Graham Number | Asset | $17.25 | 12.67x | yes | √(22.5 × EPS $0.65 × BVPS $20.39) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $23.32 | 9.37x | yes | EBITDA $1.39B × sector EV/EBITDA 16.0x |
| FCF Yield | Earnings | $18.55 | 11.78x | yes | FCF $1665.4M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $10.61 | 20.60x | yes | SBC-adj FCF $1.01B (FCF $1.67B − SBC $0.66B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $20.92 | 10.45x | yes | EPS $0.65 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $3.08 | 70.98x | yes | BV $20.39 × (ROIC 1.4% / WACC 9.0%) (excluded from median) |
| P/Sales Sector | Relative | $48.79 | 4.48x | yes | Revenue $8.72B × sector P/S 5.0x |
| PEG Fair Value | Relative | $24.32 | 8.99x | yes | EPS $0.65 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $7.01 | 31.19x | yes | EPS $0.65 / required return 9.3% (Rf 4.3% + ERP 5.0%) (excluded from median) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $1.1b |
| Net debt / NOPAT (after-tax) | 1.12x |
| Net debt / operating income (pre-tax) | 0.89x |
| Interest coverage | 6.6x |
| Share count CAGR (dilution) | 1.3% |
| Burning cash | no |
Bullet Takeaways
At $312.37 (as of June 27, 2026) the price sits far above almost every valuation method. Only the most forward DCF reaches it, by holding today's roughly 200x EV/EBITDA flat for years; the asset, earnings, and peer-multiple methods land between $18 and $50. The price is a bet on durability the static frames cannot see.
The business behind it is genuinely strong. Fiscal 2026 revenue hit a record $8.2 billion, up 42% on AI demand, and Marvell locked in more than 20 custom AI chip design wins for production in fiscal 2028 and 2029, with bookings at a record pace.
The valuation leaves no cushion. Read against sales, the price implies a roughly 20% steady-state operating margin sustained for decades, an elevated assumption that only a small minority of fast-growers have matched, in a market the company itself calls intensely competitive.
Bull Case
The most striking feature is how far the price sits above the valuation methods. At $312.37, the asset and earnings frames land near $18 to $24, the peer-multiple frames near $46 to $49, and only the most forward growth method, the DCF Exit Multiple at $324, reaches the price, and it does so by holding today's roughly 200x EV/EBITDA flat into the future. When every static frame is a fraction of the price and only the durability-crediting method clears it, the market is paying for compounding the standard models structurally cannot price. For a company at the center of the AI infrastructure build-out, that premium is the thesis, not an error.
The fundamentals justify treating Marvell as special. Fiscal 2026 revenue reached a record $8.195 billion, up 42% year over year, with GAAP net income of $2.67 billion, driven by data-center AI demand. Marvell designs custom silicon, high-speed networking, optical interconnect, and the active electrical cables that move data inside AI clusters, the filing describing techniques such as "equalization, clock recovery, forward error correction, and coded modulation" delivered through "tailor-made AECs" with cable manufacturers (FY2025 10-K, accession 0001835632-25-000057). This is deeply embedded, hard-to-displace content.
The order book makes the durability bet concrete. Design wins in fiscal 2026 hit an all-time record, and the company locked in more than 20 custom AI chip design wins set to enter production in fiscal 2028 and 2029, with bookings growing at a record pace and management guiding year-over-year revenue growth to accelerate each quarter in fiscal 2027. Custom silicon is a multi-year commitment: once a hyperscaler designs Marvell into an accelerator program, the revenue runs for the platform's life. Leverage is modest at 0.8x operating income with interest coverage near 6.7x. For a buyer who believes the custom-AI-silicon franchise compounds as the design wins ramp, the bull case is a debt-light leader riding the strongest demand curve in semiconductors, priced for exactly that.
Bear Case
The competitive disruption risk is specific and large, and it deserves naming before any multiple. Marvell's most lucrative opportunity, custom AI accelerators for hyperscalers, is the same prize Broadcom pursues with far greater scale, while Nvidia owns the merchant-GPU market the customers could default back to and AMD is investing heavily in the same data-center silicon. Worse, Marvell's own customers are its most dangerous competitors: the hyperscalers designing custom chips can pull that work in-house. The filing concedes the company operates "in intensely competitive markets" and warns that even its own integration strategy "may have a short-term adverse impact on our results of operations, as we may reduce our revenue by integrating the function"ality (FY2025 10-K, accession 0001835632-25-000057). A design socket won today can be lost at the next program.
The concentration magnifies the disruption risk. A small number of large customers drive much of Marvell's revenue, and the filing flags both customer credit concentration and export-control exposure, referencing "risks related to export restrictions that may impact certain customers in the AI, Cloud and 5G markets" (accession 0001835632-25-000057). When a handful of hyperscalers carry the growth, the loss of one program, a delay in an accelerator ramp, or a China-related restriction can move the numbers sharply, and the price assumes none of that happens for a very long time.
The valuation is where the disruption risk becomes dangerous. Read against sales, the price embeds a roughly 20.4% steady-state operating margin sustained for about 38 years of growth at the self-funding ceiling, a duration only about 15% of comparable fast-growers have matched for even a decade. Every method that prices current economics is far below: FCF yield at $19, EV/EBITDA relative at $23, Graham Number at $18, P/Sales at $49. Trailing GAAP EPS is just $0.68. The bear case does not require Marvell to fail. It requires only that Broadcom take more of the custom-silicon share, that a hyperscaler in-source one program, or that the AI build-out digest, for a price built on near-perpetual dominance to reprice violently.
Valuation
Marvell is priced against sales because trailing profit sits well below the steady state the price assumes. At $312.37 the market pays about 32.7x revenue, which inverts into an assumption that the business eventually earns a roughly 20.4% operating margin and grows revenue at its self-funding ceiling for about 38 years, computed at a 14.8% cost of capital. The model labels that elevated, and the historical base rate is stark: only about 15% of comparable fast-growers have sustained this pace for ten years, let alone the implied horizon.
The X-ray families spread enormously. The only method that reaches the price is the DCF Exit Multiple at $324, which holds today's roughly 200x EV/EBITDA flat. Every other family is far below: DCF Perpetual Growth at $78, Discounted Future Market Cap at $170, the relative methods at $46 to $49, and the earnings and asset methods at $18 to $24. The reverse-DCF reasonable band lands at just $11.83 to $19.12 with a base near $16, and its reliability is flagged low because a company growing this fast off a high revenue multiple is hard to bound. There is also a basis note: trailing EDGAR operating income and the record-basis figure differ by more than ten percent, so the normalized and spot views are explicitly different measurements.
The synthesis is a price built almost entirely on durability. The gap between a normalized band in the teens and a price above $300 is the AI-custom-silicon premium, and it is internally coherent: a debt-light leader with record design wins can justify a premium multiple. At 32.7x revenue the price requires the AI accelerator franchise to compound for decades while holding off Broadcom, Nvidia, AMD, and the customers' own in-house teams. The methods say the demonstrated business is worth a fraction of the price; the difference is a bet on persistence that leaves no room for the competitive landscape to shift.
Catalysts
The fiscal 2026 results, reported January 2026, and the strong Q1 fiscal 2027 print are the load-bearing catalysts: full-year fiscal 2026 revenue of a record $8.195 billion, up 42%, and Q1 fiscal 2027 revenue of $2.418 billion, a record, up 28% year over year (Marvell investor relations; 8-K filings, 2026). Management guided year-over-year revenue growth to accelerate each quarter in fiscal 2027 on data-center strength, with bookings at a record pace.
The forward set is the custom-silicon ramp. Marvell logged an all-time record of design wins in fiscal 2026 and locked in more than 20 custom AI chip design wins set to enter production in fiscal 2028 and 2029, so the swing factors are whether those programs ramp on schedule, the competitive outcome against Broadcom and others for new custom sockets, hyperscaler capital-spending cadence, and export-control developments affecting AI, Cloud, and 5G customers. With the stock up sharply in 2026 and the price built on long-duration growth, each guidance revision and design-win update will carry outsized weight (Money Morning; StockStory).
Sources: Marvell fiscal 2026 and Q1 fiscal 2027 results (Marvell investor relations; MRVL 8-K filings, 2026); Money Morning and StockStory earnings coverage (2026).
Peer Cohorts (Per Segment, With Filing Citations)
Integrated circuits (single reportable segment) (reported)
- AMD (ADVANCED MICRO DEVICES INC)
- (no filing in the citation store)
- NXPI (NXP Semiconductors N.V.)
- (no filing in the citation store)
- MCHP (MICROCHIP TECHNOLOGY INCORPORATED)
- (no filing in the citation store)
- ADI (ANALOG DEVICES INC)
- (no filing in the citation store)
- MPWR (MONOLITHIC POWER SYSTEMS INC)
- (no filing in the citation store)
- SWKS (SKYWORKS SOLUTIONS, INC.)
- (no filing in the citation store)
- QRVO (Qorvo, Inc.)
- (no filing in the citation store)
- CRUS (Cirrus Logic, Inc.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.